Introduction
Secreted proteins are known to regulate many aspects of early development including cell proliferation, dierentiation, and survival. Embryonal carcinoma cells have many properties in common with pluripotent cells of the early embryo and have provided a useful in vitro model for studying some aspects of embryonic development (Andrews, 1998) . Human NTERA-2 cells, for example, can be induced to dierentiate into neurons by treatment with retinoic acid (RA) whereas treatment with hexamethylene bisacetamide (HMBA) induces NTERA-2 cells to dierentiate into distinct, non-neuronal, cell types (Andrews, 1984; Andrews et al., 1986 Andrews et al., , 1990 Pleasure and Lee, 1993) . Dierentiated NTERA-2 cells have altered patterns of gene expression, changes in morphology, reduced proliferation, and are no longer tumorigenic when introduced into nude mice Dmitrovsky et al., 1990; Miller et al., , 1994 . Although treatment of NTERA-2 cells with RA and HMBA gives rise to dierent types of terminally dierentiated cells, some common pathways are activated by these agents that may correlate with a commitment to dierentiation or loss of proliferative potential. For example, expression of the growth factors FGF4 and TGFa is downregulated and expression of Wnt-13 is induced following treatment with either RA or HMBA, consistent with the hypothesis that common extracellular signaling pathways are important for multiple NTERA-2 dierentiation programs (Miller et al., 1994; Wakeman et al., 1998) . Down-regulation of the growth factors FGF4, TGFa, and TDGF-1 (CRIPTO) has been shown to contribute to the reduced proliferative and tumorigenic potential in dierentiated NTERA-2 cells (Baldassarre et al., 1996 (Baldassarre et al., , 1997 Baselga et al., 1993; Maerz et al., 1998) . In contrast, addition of recombinant bone morphogenetic protein-7 has been shown to induce dierentiation of NTERA-2 cells along a pathway distinct from that induced by RA or HMBA (Andrews et al., 1994) . At present, the roles of secreted factors that may act to promote dierentiation of pluripotent NTERA-2 cells in response to inducers such as RA and HMBA are poorly de®ned.
We have previously described a cellular repressor of E1A-stimulated genes, CREG, that antagonizes transcriptional activation and cellular transformation by the Adenovirus E1A oncoprotein (Veal et al., 1998) . CREG is a small, 220 amino acid, protein that has been conserved through evolution. Human CREG is 77% identical to mouse CREG and 31% identical to the Drosophila homolog. Although CREG was found to share limited sequence similarity with E1A, the amino acid sequence of CREG does not reveal homology to other cellular proteins. In transient transfection assays, CREG was found to repress transcription of the E1A-responsive Adenovirus E2 and cellular HSP70 promoters. Co-transfection of CREG reduced the eciency with which E1A and ras cooperated to transform primary cells. These observations suggested that, opposite to the eects of E1A, the physiological function of CREG may be to inhibit cell growth and/or to promote dierentiation. The mechanism by which CREG functions to antag-onize E1A, whether through a direct eect on transcription or through alterations in signaling pathways, was not resolved in our previous studies.
In order to investigate the biological role of CREG, we have determined the subcellular localization of CREG and examined CREG expression and activity in two well characterized cell culture models for dierentiation, mouse ES and human EC cells. Investigation of the subcellular localization and post-translational modi®cation of CREG reveals that CREG is an Nglycosylated protein that is secreted. Although CREG mRNA is broadly expressed in dierentiated adult tissues, we have found that CREG mRNA is expressed at extremely low levels in undierentiated mouse embryonic stem (ES) cells and human embryonal carcinoma (EC) NTERA-2 cells. CREG mRNA, however, is rapidly induced during in vitro dierentiation of both mouse ES and human EC cells. Constitutive expression of CREG in NTERA-2 cells stimulates the appearance of a cell type speci®c dierentiation marker in response to RA treatment. Media enriched in CREG was also found to enhance neuronal dierentiation of NTERA-2 cells in the absence of RA. The ®nding that CREG is a secreted protein that promotes dierentiation of NTERA-2 cells suggests that CREG may function to activate a signaling cascade important for dierentiation of pluripotent stem cells such as those found in teratocarcinomas.
Results

CREG is post-translationally modified by cleavage and glycosylation
To gain insight into the biological activity of CREG, we have investigated the subcellular localization of the CREG protein. Immuno¯uorescent staining with anti-CREG antibodies was used to visualize CREG in cells transfected with CMV-hCREG. As shown in Figure  1a , CREG protein was excluded from the nucleus and concentrated in the perinuclear region of the cell. This pattern is reminiscent of endoplasmic reticulum (ER) and golgi staining. Analysis of the human CREG amino acid sequence with the Psort program identi®ed the ®rst 31 amino acids of CREG as a potential cleavable signal sequence targeting CREG to the secretory pathway. Strikingly, this predicted signal sequence is conserved in the mouse and Drosophila CREG proteins as well. In order to test the role of the putative N-terminal signal sequence, a deletion mutant lacking the ®rst 31 amino acids, CREGD31N, was generated. Full-length and CREGD31N proteins were translated in vitro, in the presence and absence of microsomes. As shown in Figure 1b , full-length CREG is retained in microsomes where it is extensively modi®ed giving rise to three forms of apparently higher molecular weight as well as a smaller product and these modi®ed forms are resistant to trypsin treatment. In contrast, CREGD31N is neither subject to modi®cation nor protected from trypsin digestion in the presence of microsomes. Note that the size of the smallest form of CREG generated in the presence of microsomes is consistent with cleavage of the predicted signal sequence. These observations indicate that CREG has an N-terminal signal sequence which is necessary for entry into the ER.
The appearance of several higher molecular weight forms of CREG in the presence of microsomes in vitro suggested that CREG may be subject to posttranslational modi®cation by N-glycosylation in vivo. There are three consensus N-glycosylation sites within human CREG, two of which are conserved in the mouse protein. In order to examine if CREG is glycosylated in vivo, metabolically labeled CREG was immunoprecipitated from transfected cell lysates and some of the immunoprecipitates were treated with peptide-N-glycosidase F (PNGaseF). As shown in Figure 1c , three forms of CREG can be seen after transfection, and treatment with PNGaseF abolished the higher molecular weight forms of CREG in favor of a single band smaller in size than the in vitro translated protein. These data indicate that CREG is post-translationally modi®ed by both cleavage and Nglycosylation in mammalian cells.
CREG is a secreted glycoprotein
Since the sequence of CREG does not appear to contain any intracellular localization signals in addition to the N-terminal signal sequence, we considered the possibility that CREG may be secreted from the cell. Immunoprecipitation experiments were therefore performed with both tissue culture media and cell lysates prepared from metabolically labeled cells transfected with CMVhCREG. Diuse bands of labeled protein corresponding in size to CREG were observed in the immunoprecipitates from the media of CMVhCREG transfected cells, but not control cells, indicating that CREG was indeed secreted from the cells (Figure 2a ). To con®rm that the presence of CREG in the medium was due to active secretion and not the result of loss of cell membrane integrity, cells were transfected with either full-length CREG or the D31N mutant, which lacks the signal sequence. Immunoprecipitates were treated with PNGaseF which reduces CREG to a single band. As expected, detectable amounts of CREGD31N could only be immunoprecipitated from cell extracts and not from the medium, indicating that the presence of wild type CREG in the medium is due to active secretion from cells ( Figure 2b ). Endogenous CREG protein can also be detected in the tissue culture supernatants of several cell lines including dierentiated NTERA-2 cells (Figure 5c and data not shown).
CREG mRNA is broadly expressed in adult tissues and is regulated during embryonic development In order to determine the tissue distribution of CREG mRNA, a Northern blot of RNA extracted from various adult mouse tissues was hybridized with a probe containing part of the open reading frame and 3'UTR of the mouse CREG cDNA. As shown in Figure 3a , two CREG transcripts were found to be expressed in all the tissues examined. Hybridization of Northern blots with additional probes and analysis of sequence data derived from multiple ESTs indicates that although the longer transcript contains additional 3'UTR sequences, both messages encode the same CREG open reading frame (data not shown). Although it is not currently known if the presence of the 3'UTR aects the stability of the CREG transcript, it is interesting to note that the ratio of the two transcripts varies in dierent tissues. In similar studies, CREG mRNA was also found to be widely expressed in human adult tissues and in several human cell lines (data not shown). Northern blot analysis of RNA extracted from mouse embryos showed that although CREG mRNA is expressed at the earliest time point examined, 7 days, CREG mRNA levels increase dramatically during embryonic development ( Figure 3b ).
CREG mRNA levels increase during in vitro differentiation of mouse embryonic stem cells
The increase in expression of CREG mRNA during development of the mouse embryo suggested that CREG expression might be up regulated during dierentiation. To investigate changes in CREG expression during dierentiation, the level of CREG mRNA was examined during the in vitro dierentiation of mouse embryonic stem (ES) cells. When Keller, 1995) . RNA was extracted from undierentiated ES cells, grown in the presence of Leukaemia inhibitory factor (LIF), and from cells allowed to dierentiate in suspension for dierent lengths of time. Northern analysis revealed that CREG mRNA was expressed at extremely low levels in undierentiated ES cells (Figure 4 ). CREG transcript levels began to increase 4 days after removal of LIF and continued to increase up to at least 9 days, by which time it was about 30-fold its original level. Although HPRT mRNA levels remained constant, our analysis also detected a sharp increase in the bHI globin mRNA 4 ± 5 days after removal of LIF, indicative of early hematopoeitic dierentiation (Figure 4a ). During in vitro dierentiation, a single embryoid body contains cells which are dierentiating along multiple dierent pathways, thus it is possible that the observed increase in CREG mRNA levels is associated with multiple dierentiation programs.
CREG mRNA expression is rapidly induced during differentiation of embryonal carcinoma cells
To investigate whether the induction of CREG expression is an early event in multiple dierentiation pathways, we examined the expression of CREG during dierentiation of the human teratocarcinomaderived NTERA-2 cell line. Treatment of pluripotent NTERA-2 cells with RA induces dierentiation into neurons and other cell types, whereas treatment with HMBA induces dierentiation of distinct non-neuronal cell types (Andrews, 1984; Andrews et al., 1986 Andrews et al., , 1990 Pleasure and Lee, 1993) . NTERA-2 cells were induced to dierentiate with either RA or HMBA and RNA was extracted at various timepoints. Northern analysis revealed that, as observed in the mouse ES cells, undierentiated NTERA-2 cells do not express signi®cant levels of CREG mRNA. Treatment with either RA or HMBA resulted in a rapid induction of hCREG mRNA (Figure 5a,b) . CREG mRNA levels increased 15 ± 20-fold within 4 h of treatment with either HMBA or RA (Figure 5b ). The increase in CREG mRNA in response to RA was earlier than the induction of Hox 2.1, an established early marker of RA-induced NTERA-2 dierentiation which, unlike CREG, is not induced in response to HMBA (Figure 5a ) (Miller et al., 1994; Simeone et al., 1990) . Similar to CREG mRNA, CREG protein was also induced upon treatment with HMBA and RA ( Figure 5c and data not shown). As shown in Figure 5c , CREG protein is undetectable in the media of undierentiated NTERA-2 cells but the level of extracellular CREG increased upon treatment with HMBA. The observation that CREG mRNA levels are rapidly induced in response to both RA and HMBA suggests that CREG may play a role in an early step common to multiple dierentiation pathways.
Overexpression of CREG promotes differentiation
The rapid increase in CREG mRNA levels during ES and EC cell dierentiation in vitro suggested that CREG might function early during dierentiation. The dierentiation of NTERA-2 cells in response to RA is well-characterized and antibodies to cell surface markers that can be used to distinguish dierentiated from undierentiated cells have been described (Andrews, 1984; Andrews et al., 1986) . Therefore, the eect of CREG overexpression on dierentiation was examined in these cells. Pools of NTERA-2 cells stably transfected with a CMV vector (NCMV) or CMVhCREG (NC1 and NC2) were selected. Immunoprecipitation and blotting with anti-CREG antisera con®rmed that two independent pools of cells, NC1 and NC2, constitutively express high levels of CREG (Figure 6a ). The stable transfectants were treated with RA or DMSO, the vehicle for RA, and then analysed by FACs to determine the proportion of cells expressing the A2B5 cell surface antigen, a marker of neuronal dierentiation (Eisenbarth et al., 1979) . Cells were examined after 5 days treatment with RA, since we reasoned that any eect of CREG on dierentiation might be more easily detected at early times when not all cells in the population had dierentiated. As shown in Figure 6b , about twice as many of the NC1 and NC2 cells overexpressing CREG were A2B5 positive after 5 days of RA treatment compared to cells stably transfected with the vector. Consistent with the hypothesis that overexpressing CREG promotes dierentiation, expression of stage speci®c embryonic antigen-3, SSEA3, a cell-surface marker characteristic of undierentiated EC cells (Shevinsky et al., 1982) , was lower in NC1 and NC2 following RA treatment (Figure 6c) . Interestingly, the NC1 and NC2 cells expressed slightly lower levels of the embryonic SSEA3 antigen in the absence of inducer, raising the possibility that CREG expression may promote a low level of spontaneous dierentiation of these cells.
Since CREG is a secreted glycoprotein, we wished to determine if extracellular CREG could promote NTERA-2 dierentiation. Tissue culture supernatants enriched in secreted CREG were obtained after transfection of 293T cells with CMVhCREG. Media from CMVhCREG transfected cells or control vector transfected cells was added to NTERA-2 cells and the expression of A2B5 and SSEA3 antigens monitored by FACs. Consistent with the results obtained with cells overexpressing CREG, NTERA-2 cells grown in CREG-enriched media showed enhanced dierentiation upon stimulation with RA (data not shown). More strikingly, however, in the absence of RA, NTERA-2 cells grown 5 days in media containing Figure 4 CREG expression is induced during in vitro dierentiation of mouse embryonic stem cells. (a) A blot containing RNA isolated from undierentiated ES cells grown in the presence of Leukaemia inhibitory factor (LIF) or from cells allowed to dierentiate in suspension for 3, 6, and 9 days was hybridized with a mouse CREG cDNA probe. The same blot was hybridized with bH1 globin, a known marker of hematopoetic dierentiation, and with HPRT to con®rm that the RNA samples were loaded evenly. (b) RNA isolated from undierentiated ES cells or from cells allowed to dierentiate in suspension for 1 ± 6 days were hybridized with a mouse CREG cDNA probe. The relative amount of CREG mRNA at the indicated timepoints as determined by phosphoimager analysis is plotted here. Analysis of the 2.2 and 1.0 kb mRNAs reveals that the timing and level of induction of both CREG transcripts were similar Secreted CREG promotes NTERA-2 differentiation E Veal et al soluble CREG showed an almost twofold increase in expression of the neuronal A2B5 marker and a corresponding reduction in the expression of the embryonic SSEA3 marker compared to cells grown in control media ( Figure 7 ). As noted earlier, the NC1 and NC2 cells constitutively expressing CREG showed only modest decreases in SSEA-3 expression in the absence of RA, whereas high levels of CREG in the media signi®cantly increased the likelihood of dierentiation by NTERA-2 cells in the absence of an inducer. Since the conditioned media provides higher levels of CREG than the stable overexpressing cells (data not shown), this dierence may indicate that the response to CREG is dose-dependent.
Discussion
We report here that the cellular repressor of E1A genes, CREG, is a secreted glycoprotein which enhances dierentiation of the human embryonal carcinoma cell line NTERA-2. Overexpression of CREG in NTERA-2 cells enhanced the appearance of the neural-speci®c A2B5 marker and reduced expression of the embryonic antigen SSEA3 in response to RA treatment. We have found that addition of extracellular CREG to NTERA-2 cells consistently increased the appearance of dierentiated cells, even in the absence of an inducer such as RA. Thus, CREG functions to promote dierentiation of pluripotent cells derived from a human teratocarcinoma. CREG mRNA expression is induced early during dierentiation of human EC cells and mouse ES cells in culture, and CREG mRNA is expressed in many adult tissues. The expression pattern of the CREG transcript indicates that CREG may act to promote dierentiation in many dierent lineages during development. CREG was initially isolated in a yeast two-hybrid screen due to its interaction with the TATA-binding protein, TBP (Veal et al., 1998) . In transfection assays, CREG was found to antagonize transcriptional activation and cellular transformation by the adenovirus E1A oncoprotein. Since E1A inhibits dierentiation, we proposed that CREG may have the opposite activity, and we have now shown that CREG does, in fact, promote dierentiation. The ®nding that CREG is a secreted glycoprotein protein makes it unlikely that CREG binding to the general transcription factor TBP and the tumor suppressor pRB are important for CREG activity, as previously proposed. Rather, we now favor a model in which CREG acts by binding directly to a cell surface receptor or by altering the interaction of another secreted ligand with its cognate receptor. According to this model, binding of extracellular CREG to its receptor initiates a signal transduction cascade leading to changes in gene expression in the nucleus. Expression of E1A-responsive target genes is hypothesized to be aected by this signaling pathway, accounting for the observation that CREG antagonizes transcriptional activation by E1A. Although CREG has been evolutionarily conserved from Drosophila to man, the amino sequence of CREG does not reveal homology to other characterized signaling proteins. Studies to identify a receptor for CREG and characterize the downstream signaling events are likely to yield important insight into CREGs mechanism of action.
Dierentiation of NTERA-2 cells leads to the expression of cell type-speci®c antigens, an eventual inhibition of proliferation, and a loss of tumorigenicity (Andrews, 1984; Andrews et al., 1986 Andrews et al., , 1990 Dmitrovsky et al., 1990; Miller et al., 1994) . Previous studies have shown that overexpression of either RARg or RXRb in NTERA-2 cells leads to high levels of dierentiation and a concomitant inhibition of proliferation in the absence of RA (Moasser et al., 1995; Spinella et al., 1998) . Growth arrest and morphologic dierentiation was observed several weeks after induction of RXRb overexpression . Interestingly, overexpression of either RARg or RXRb alone induced dierentiation of distinct non-neuronal cell types, but together these factors induced a neuronal phenotype (Moasser et al., 1995; . To our knowledge, this is the ®rst study examining the eects of overexpressing a secreted protein that is up-regulated during NTERA-2 dierentiation. Interestingly, the phenotype observed when CREG is overexpressed in these cells is dierent from the eects of constitutive expression of other proteins implicated in the control of NTERA-2 cell growth and dierentiation (Baselga et al., 1993; Maerz et al., 1998; Moasser et al., 1995; Spinella et al., 1998) . We have found that CREG increases the number of cells that dierentiate both in the absence of an inducer and in response to RA. In our studies, only a fraction of the NTERA-2 cells were observed to spontaneously dierentiate when cultured in the presence of high levels of CREG. Although it is possible that prolonged incubation, beyond the 5 days tested here, might lead to higher levels of dierentiation induced by CREG, it is also possible that CREG alone is insucient to promote dierentiation of the entire culture in the absence of additional signaling molecules not overexpressed in our assays.
Although we have found that CREG enhances dierentiation, we do not believe that CREG is sucient to determine cell lineage. As shown here, overexpression of CREG enhances neuronal dierentiation stimulated by RA. In similar experiments, we have found that in response to HMBA treatment, the CREG-overexpressing NC1 cells showed enhanced expression of Vinis-53 immunoreactivity, a marker for a non-neuronal cell type (data not shown), suggesting that high levels of CREG stimulate dierentiation into a lineage determined by the inducer. We have shown that, in the absence of an inducer, high levels of CREG in the media are sucient to stimulate some cells to dierentiate into A2B5-positive neuroectoderm, but not Vinis-53 positive cells (Figure 7 and data not shown). Neural dierentiation has been suggested to be a default pathway for dierentiation of embryonic cells in the absence of other lineage-speci®c signals (Hemmati-Brivanlou and Melton, 1997) . It is likely, therefore, that high levels of CREG stimulate neural dierentiation in NTERA-2 cells due to the absence of a lineage-speci®c inducer. In vivo, CREG may function together with lineage-speci®c signaling proteins to promote dierentiation of multiple cell types.
The expression pattern of CREG suggests that it may be involved in an early step of dierentiation of pluripotent stem cells common to many lineages. We have examined CREG expression in several cell lines and, to date, the only cells that do not express signi®cant levels of CREG mRNA are pluripotent ES and EC cells. The induction of CREG in response to two dierent dierentiation pathways in NTERA-2 cells and the observation that CREG mRNA is broadly expressed in dierentiated adult tissues indicates that CREG is not restricted to a single cell type. CREG mRNA induction is an early event and occurs well before terminal dierentiation in both ES and NTERA-2 cells. The data presented here suggest that CREG is a novel secreted protein that acts to potentiate a common step during dierentiation of many lineages. Future studies of CREG expression and activity during development may provide insights into common extracellular signaling pathways important for dierentiation of pluripotent stem cells into multiple lineages.
Materials and methods
Plasmids and in vitro assays of post-translational modification
CMVhCREG contains the human CREG open reading frame under the control of the CMV promoter (Veal et al., 1998) . The CREG signal sequence was identi®ed using the Psort program at http://psort.nibb.ac.jb:8800/. CREGND31, corresponding to CREG aa 32 ± 220, was generated by PCR and cloned into the HindIII and XbaI sites of Rc/CMV. In vitro transcription and translation were performed in rabbit reticulocyte lysates in the presence or absence of 1.5 ml dog pancreas microsomes (TNT Kit, Promega). After 90 min at 308C, microsomes were pelleted by centrifugation and washed with 250 mM sucrose, 10 mM Tris, pH 7.5. The indicated samples were then treated with trypsin (0.1 mg/ml) for 30 min at 48C prior to analysis by SDS ± PAGE.
Cell culture and in vitro differentiation
HeLa, CV-1, 293T, and NTERA-2 cells were grown in Dulbecco's Modi®ed Eagle's Medium (DMEM) containing 10% fetal calf serum (FCS), 5 mM penicillin and 5 mM streptomycin. For dierentiation, NTERA-2 cells were plated in the same medium containing either 10 mM retinoic acid (RA) or 5 mM hexamethylene bisacetamide (HMBA). CJ7 mouse embryonal stem (ES) cells were grown in DMEM containing 15% FCS, 5 mM penicillin, 5 mM streptomycin, 150 mM monothioglycerol (MTG) and 1000 units per ml Leukaemia inhibitory factor (LIF) on gelatin-coated plates. For dierentiation, ES cells were plated out at 5000 cells per ml on 10 cm plates in Iscoves Modi®ed Dierentiation Medium+15% FCS.
RNA extraction and Northern hybridization
RNA was extracted by an adaptation of the protocol of Chomczynski and Saachi (1987) . Ten mg RNA was denatured, separated by electrophoresis on a 6% formaldehyde/ 1% agarose gel, and transferred to a Hybond-N + (Amersham) membrane. Hybridization with 32 -P-labeled cDNA probes was carried out using Quikhyb (Stratagene). Amounts of CREG mRNA in ES cells were determined by phosphoimager analysis relative to HPRT mRNA and in NTERA-2 cells by scanning densitometry relative to GAPDH mRNA.
Antibodies and immunostaining of transfected cells
66HIS-hCREG fusion protein was puri®ed from bacteria and used to immunize mice. Puri®ed GST+hCREG fusion protein was used to immunize rabbits. Rabbit antisera was anity puri®ed to select for anti-CREG antibodies. HeLa cells plated on coverslips were transfected by calcium phospate precipitation. Cells were ®xed with cold methanol (7208C) at room temperature for 2 min. Fixed cells were washed three times with PBS, three times with 3% BSA in PBS, and then incubated overnight at 48C with 1 : 500 dilution of anti-hCREG mouse polyclonal antiserum in 3% BSA in PBS. Coverslips were washed three times with 3% BSA in PBS and incubated with 1 : 50 dilution of Texas Red conjugated sheep anti-mouse antibody (Amersham) for 1 h at room temperature in the dark. Coverslips were washed once with PBS, Hoechst stained, washed three times with 3% BSA in PBS, then mounted in Vectashield.
S-methionine metabolic labeling of transfected cells
CV-1 cells were transfected by calcium phosphate precipitation of DNA followed by a 3 min glycerol shock and exposure to 5 mM sodium butyrate overnight. 293T cells were transfected using LipofectAMINE (GIBCO ± BRL). Twenty to twenty-six hours after transfection, the medium was removed and the cells were incubated for 1 h in DMEM lacking methionine and cysteine and supplemented with 5% FCS, 5 mM penicillin and 5 mM streptomycin. Cells were then incubated in 1 ± 3 ml of this medium containing 200 mCi/ml of 35 S-methionine/cysteine. After 3 h, the medium was removed and cells were washed with PBS then harvested in NP40 lysis buer (50 mM Tris.Cl pH 8, 1% NP40, 150 ± 300 mM NaCl, and protease inhibitors; for the 293T cells 5 mM MgCl 2 and 5% glycerol was also included). The presence of CREG in both the media and cell lysate was determined by immunoprecipitation.
Immunoprecipitation and immunoblotting with anti-CREG antisera
For immunoprecipitation from NTERA-2 and 293T cells, clari®ed cell lysates prepared with NP40 lysis buer were diluted with an equal volume of 50 mM Tris pH 8; media was centrifuged to remove cells. Samples were incubated overnight with anity-puri®ed polyclonal rabbit anti-hCREG antiserum diluted 1 : 300 (cell lysates) or 1 : 1000 (media). Forty ml of a protein A/protein G Sepharose bead slurry was added and incubated for 2 h at 48C, then washed four times with NP40 washing buer. For immunoprecipitation from CV-1 cells, transfected cell lysate or media was incubated for 2 h at 48C with 30 ml of a Protein G Sepharose slurry prebound to polyclonal mouse anti-hCREG antiserum. Immunoprecipitates were analysed directly or resuspended in 30 ml NP40 lysis buer for deglycosylation. To deglycosylate the proteins, 2 ml denaturing buer was added and the sample incubated at 1008C for 10 min. 2 ml 106G7 buer, 2 ml 10% NP40 and 2 ml peptide-N-glycosidase F (PNGaseF) were added and the sample incubated at 378C for 1 h.
Immunoprecipitates were separated by SDS ± PAGE. Metabolically labeled extracts were visualised by autoradiography; unlabeled samples were blotted with polyclonal mouse anti-CREG antisera.
Generation of stably transfected cells
NTERA-2 cells were transfected with 10 mg Rc/CMV, CMVhCREG, or a control plasmid lacking the neomycin resistance gene by calcium phosphate precipitation. Forty hours after transfection, the media was replaced with complete media containing 500 mg/ml neomycin (G418). This concentration of G418 was sucient to kill all the control transfected NTERA-2 cells within 7 days. At this time the Rc/CMV and CMVCREG transfected plates, which were about 50% con¯uent, were replated. Pools of stably transfected NTERA-2 cells were maintained in media containing 500 mg/ml neomycin.
Production of CREG-enriched media
293T cells were transfected with CMV-hCREG or CMV vector using lipofectamine (GIBCO ± BRL). Twenty hours after transfection the media was replaced with complete DMEM and after 2 h this was replaced by serum-free DMEM and cultured an additional 2 days. The conditioned media was harvested and any cells removed by centrifugation. Conditioned media was supplemented with 10% FCS before adding to NTERA-2 cells. NTERA-2 cells were cultured in the conditioned media for 5 days and assayed as described below.
FACS analysis of NTERA-2 differentiation
Stably transfected NTERA-2 cell pools were seeded at 10 5 cells per ml and treated with 10 mM RA or vehicle (0.1% DMSO) for 5 days. Cells were split on day 3 and allowed to grow 2 more days in the presence of RA or DMSO. Cells were harvested and analysed by indirect¯ow cytometry using monoclonal antibodies to the cell surface antigens recognized by SSEA3 (Shevinsky et al., 1982) and A2B5 (Eisenbarth et al., 1979) . A2B5 antibodies were obtained from hybridoma cultures purchased from ATCC; SSEA3 antisera was from the Developmental Studies Hybridoma Bank (University of Iowa). Cells were indirectly assayed with FITC-(Fluorescein Isothiocyanate) conjugated goat anti-mouse antibodies (KPL) as described (Kurie et al., 1993; Moasser et al., 1996) . The percentage of positive cells expressing above a threshold amount of antigen was measured in the entire population.
